The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
スポンサーリンク
概要
- 論文の詳細を見る
Developing effective drug therapies for arrhythmic diseases is hampered by the fact that the same drug can work well in some individuals but not in others. Human induced pluripotent stem (iPS) cells have been vetted as useful tools for drug screening. However, cardioactive drugs have not been shown to have the same effects on iPS cell-derived human cardiomyocytes as on embryonic stem (ES) cell-derived cardiomyocytes or human cardiomyocytes in a clinical setting. Here we show that current cardioactive drugs affect the beating frequency and contractility of iPS cell-derived cardiomyocytes in much the same way as they do ES cell-derived cardiomyocytes, and the results were compatible with empirical results in the clinic. Thus, human iPS cells could become an attractive tool to investigate the effects of cardioactive drugs at the individual level and to screen for individually tailored drugs against cardiac arrhythmic diseases.
論文 | ランダム
- 名誉会員となられたHenry Taube先生
- 機能性金属錯体の開発 - 分子で脳機能にせまりたい -
- Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro
- ヒト扁平上皮癌細胞のブレオマイシン (BLM) 耐性獲得に関する研究 : 第2報 BLM耐性HeLa細胞によリヌードマウスに形成された腫瘍のBLM感受性と耐性形質の安定性
- ヒト扁平上皮癌細胞のブレオマイシン (BLM) 耐性獲得に関する研究 : 第4報ヒト口腔癌培養細胞からのBLM耐性細胞の樹立